NCT05457075View on ClinicalTrials.gov

Immune Checkpoints in Predicting Response to Neoadjuvant Therapy in Rectal Cancer

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

February 15, 2023

Conditions
Rectal Cancer
Interventions
DIAGNOSTIC_TEST

Immune checkpoint measure

The measurement of soluble immune checkpoints of stage II-III rectal cancer before neoadjuvant treatment

Trial Locations (1)

34098

Istanbul Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Istanbul Training and Research Hospital

OTHER_GOV